Liquidia Technologies Inc (LQDA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Roger A. Jeffs
Employees:
50
P.O. BOX 110085, RESEARCH TRIANGLE PARK, NC 27709
919.328.4400

Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.

Data derived from most recent annual or quarterly report
Market Cap 513.625 Million Shares Outstanding64.688 Million Avg 30-day Volume 526.443 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.14
Price to Revenue26.3802 Debt to Equity0.0 EBITDA-30.261 Million
Price to Book Value5.4723 Operating Margin-197.98059999999998 Enterprise Value352.364 Million
Current Ratio14.617 EPS Growth0.304 Quick Ratio14.449
1 Yr BETA 1.0278 52-week High/Low 8.82 / 3.38 Profit Margin-217.389
Operating Cash Flow Growth13.2608 Altman Z-Score1.8726 Free Cash Flow to Firm 6.369 Million
Earnings Report2023-08-03
View SEC Filings from LQDA instead.

View recent insider trading info

Funds Holding LQDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LQDA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2020-11-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-10-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-10-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-08-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-07-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-07-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-06-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LIPPE ROBERT A CHIEF OPERATIONS OFFICER

    • Officer
    188,524 2023-02-28 5

    KASETA MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    174,253 2023-02-28 6

    MOOMAW SCOTT CHIEF COMMERCIAL OFFICER

    • Officer
    100,984 2023-02-28 6

    SCHUNDLER RUSSELL GENERAL COUNSEL

    • Officer
    388,126 2023-02-28 6

    JEFFS ROGER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    2,085,011 2023-01-11 6

    SAGGAR RAJEEV CHIEF MEDICAL OFFICER

    • Officer
    284,005 2023-01-11 3

    CALIGAN PARTNERS LP

    JOHNSON DAVID EDWARD

    • Director
    • 10% Owner
    • SEE REMARKSSEE REMARKS
    10,643,627 2022-09-06 1

    KIRSCH ARTHUR S

    • Director
    20,000 2022-06-17 1

    BLOCH STEPHEN M

    • Director
    20,000 2022-06-17 1

    MANNING PAUL B

    • Director
    20,000 2022-06-17 1

    HOROBIN JOANNA

    • Director
    20,000 2022-06-17 1

    SINGH RAMAN

    • Director
    20,000 2022-06-17 1

    JOHNSON DAVID EDWARD

    • Director
    • 10% Owner
    20,000 2022-06-17 1

    RIELLY-GAUVIN KATHERINE

    • Director
    20,000 2022-06-17 1

    DEGOA DAMIAN

    • Director
    20,000 2022-06-17 1

    SHAH TUSHAR CMO AND HEAD OF R&D

    • Officer
    105,000 2022-01-16 0

    ADAIR JASON V.P. CRP DVLPMNT AND STRTGY

    • Officer
    10,000 2021-07-21 0

    ESHELMAN VENTURES, LLC

    ESHELMAN FREDRIC N

    • 10% Owner
    No longer subject to file 2021-01-26 0

    KRAWCHICK FLORINA SVP, HUMAN RESOURCES

    • Officer
    0 2021-01-19 0

    FOWLER NEAL FRANKLIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    78,512 2020-11-19 0

    BARIAHTARIS STEVEN INTERIM CHIEF FINANCIAL OFCR.

    • Officer
    0 2020-08-20 0

    SNYDERMAN RALPH

    • Director
    0 2020-06-22 0

    RUDNICK SETH

    • Director
    0 2020-06-22 0

    MAYNOR BENJAMIN SVP, RESEARCH AND DEVELOPMENT

    • Officer
    9,158 2020-05-27 0

    KATZ RICHARD D CHIEF FINANCIAL OFFICER

    • Officer
    10,833 2020-03-18 0

    ROSCIGNO ROBERT F SVP, PRODUCT DEVELOPMENT

    • Officer
    8,333 2020-03-18 0

    THOMAS JERI SVP, COMMERCIAL

    • Officer
    8,333 2020-03-18 0

    CANAAN VIII LP

    CANAAN PARTNERS VIII LLC

    • 10% Owner
    2,917,169 2019-12-27 0

    ALBURY TIMOTHY SVP, CHIEF ACCOUNTING OFFICER

    • Officer
    38,963 2019-08-22 0

    GORDON KEVIN K PRESIDENT AND CFO

    • Officer
    162,265 2019-02-22 0

    PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

    WILDCAT ACQUISITION HOLDINGS (UK) LTD

    JAGUAR HOLDING CO II

    JAGUAR HOLDING CO I, LLC

    EAGLE HOLDING CO II, LLC

    EAGLE HOLDING CO I

    • 10% Owner
    No longer subject to file 2018-07-30 0

    BARRIS PETER J

    • 10% Owner
    2,525,572 2018-07-30 0

    GLAXOSMITHKLINE PLC

    • FORMER 10% HOLDER
    624,422 2018-07-30 0

    PAPPAS ARTHUR M

    A.M. PAPPAS LIFE SCIENCE VENTURES IV LP

    PV IV CEO FUND, L.P.

    AMP&A MANAGEMENT IV, LLC

    PAPPAS CAPITAL, LLC

    • 10% Owner
    No longer subject to file 2018-07-30 0

    BARRETT M JAMES

    • 10% Owner
    2,525,572 2018-07-30 0

    KERINS PATRICK J

    • 10% Owner
    2,525,572 2018-07-30 0

    SANDELL SCOTT D

    • 10% Owner
    2,525,572 2018-07-30 0

    BASKETT FOREST

    • 10% Owner
    2,525,572 2018-07-30 0

    NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

    NEA PARTNERS 12, LIMITED PARTNERSHIP

    NEA 12 GP, LLC

    • 10% Owner
    2,525,572 2018-07-30 0

    MORNINGSIDE VENTURE INVESTMENTS LTD

    • 10% Owner
    No longer subject to file 2018-07-30 0

    LEERINK REVELATION HEALTHCARE FUND I, L.P.

    LEERINK REVELATION HEALTHCARE FUND I GP, L.P.

    • 10% Owner
    No longer subject to file 2018-07-30 0

    SOVEREIGN'S CAPITAL II, LP

    • 10% Owner
    No longer subject to file 2018-07-30 0

    BILL & MELINDA GATES FOUNDATION

    • 10% Owner
    797,073 2018-07-30 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    No longer subject to file 2018-07-30 0

    MEDICAL MUTUAL HOLDINGS, INC.

    • 10% Owner
    No longer subject to file 2018-07-30 0

    MARIO FAMILY CREDIT LLC SERIES D

    MARIO JEREMY

    MELMOTTE LLC

    • 10% Owner
    No longer subject to file 2018-07-30 0

    ALWP CAPITAL SPC LTD

    AL WEALTH PARTNERS PTE. LTD.

    • 10% Owner
    No longer subject to file 2018-07-30 0

    XERAYA LT LTD

    ZAHIR FARES

    • 10% Owner
    No longer subject to file 2018-07-30 0

    WAKEFIELD GROUP III, LLC

    • 10% Owner
    No longer subject to file 2018-07-30 0

    WAKEFIELD GROUP IV, LLC

    • 10% Owner
    No longer subject to file 2018-07-30 0

    UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL FOUNDATION, INC.

    • 10% Owner
    No longer subject to file 2018-07-30 0

    GARDEN EAST LTD

    BATHURST ENTERPRISES LTD

    • 10% Owner
    No longer subject to file 2018-07-30 0

    1118 LTD

    BATHURST ENTERPRISES LTD

    • 10% Owner
    No longer subject to file 2018-07-30 0

    AMEREUS GROUP PTE LTD

    VOROBYEV MAXIM YURYEVICH

    • 10% Owner
    No longer subject to file 2018-07-30 0

    NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

    NEA PARTNERS 12, LIMITED PARTNERSHIP

    NEA 12 GP, LLC

    BARRETT M JAMES

    BARRIS PETER J

    BASKETT FOREST

    KERINS PATRICK J

    SANDELL SCOTT D

    • 10% Owner
    11,120 2018-07-25 0

    MATHERS EDWARD T

    • Director
    0 2018-07-25 0

    GLIDDEN SHAWN SVP, LEGAL AFFAIRS AND SCRTRY

    • Officer
    16,875 2018-07-25 0

    DESIMONE JOSEPH

    DESIMONE SUZANNE

    • 10% Owner
    169,165 2018-07-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LIQUIDIA CORP LQDA 2023-05-31 22:15:04 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 21:45:04 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 21:15:03 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 20:45:04 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 20:15:06 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 19:45:04 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 19:15:21 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 18:45:03 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 18:15:04 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 17:45:03 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 17:15:05 UTC 4.2001 0.8599 2400000
    LIQUIDIA CORP LQDA 2023-05-31 16:45:04 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 16:15:04 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 15:45:03 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 15:15:04 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 14:45:04 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 14:15:03 UTC 4.1993 0.8707 2400000
    LIQUIDIA CORP LQDA 2023-05-31 13:45:04 UTC 4.1095 0.9605 2400000
    LIQUIDIA CORP LQDA 2023-05-31 13:15:04 UTC 4.1095 0.9605 2400000
    LIQUIDIA CORP LQDA 2023-05-31 12:45:04 UTC 4.1095 0.9605 2400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments